Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

2,959 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities

NCT00935077

Conditions
Asthma, Bronchial Diseases, Cardiovascular Diseases, +9 more
Locations
  • University of California San Diego San Diego, California, United States
  • St. Francis Hospital Medical Center Hartford, Connecticut, United States
  • University of Florida Gainesville, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 28 locations
View Trial Details
Completed

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

NCT01340209

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.464.81020 Boehringer Ingelheim Investigational Site Asahikawa, Hokkaido, Japan
  • 205.464.81031 Boehringer Ingelheim Investigational Site Atsugi, Kanagawa, Japan
  • 205.464.81029 Boehringer Ingelheim Investigational Site Chigasaki, Kanagawa, Japan
  • 205.464.81011 Boehringer Ingelheim Investigational Site Chino, Nagano, Japan
View all 55 locations
View Trial Details
Completed

Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma

NCT00467740

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood Lakewood, California, United States
  • 1222.6.062 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1222.6.066 Allergy & Asthma Medical Group and Rsrch Ctr, APC San Diego, California, United States
  • 1222.6.069 Allergy Associates Medical Group San Diego, California, United States
View all 37 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.

NCT01013753

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 1222.27.43002 Boehringer Ingelheim Investigational Site Linz, Austria
  • 1222.27.43004 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria
  • 1222.27.43001 Boehringer Ingelheim Investigational Site Thalheim bei Wels, Austria
  • 1222.27.43003 Boehringer Ingelheim Investigational Site Vienna, Austria
View all 27 locations
View Trial Details

Related conditions